Evidence map›Paper›PMID 31058720›Full record

ArticleShock (Augusta, Ga.)2019

The Association of Fever and Antipyretic Medication With Outcomes in Mechanically Ventilated Patients: A Cohort Study.

Emily M Evans, Rebecca J Doctor, Brian F Gage, Richard S Hotchkiss, Brian M Fuller, Anne M Drewry

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Shock (Augusta, Ga.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04494867 (Core Warming of COVID-19 Patients Undergoing Mechanical Ventilation), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04494867 nacompletednot on this mapstarted 2020, after this paper: background citation

Core Warming of COVID-19 Patients Undergoing Mechanical Ventilation: a Randomized, Single Center Pilot Study

TypeinterventionalSponsorSharp HealthCareRan2020 to 2022Enrolled20ConditionsCovid19ArmsCore Warming, Standard of Care
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Temperature control in sepsis.Frontiers in medicine · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Emily M EvansDepartment of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Rebecca J DoctorDepartment of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Brian F GageDivision of General Medical Sciences, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Richard S HotchkissDepartment of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Brian M FullerDepartment of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Anne M DrewryDepartment of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Washington University in St. Louis · USCovenant College · USSaint Louis University · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
Washington University Institute of Clinical and Translational Sciences (TL1)TL1TR002344 · NCATS · WASHINGTON UNIVERSITY · PI Jay F. Piccirillo · 2017 to 2026
$8.5M
Enhancing Innate and Adaptive Immunity to Improve Sepsis SurvivalR35GM126928 · NIGMS · WASHINGTON UNIVERSITY · PI Richard Samuel Hotchkiss · 2018 to 2026
$4.7M
NCATS NIH HHS KL2 TR000450NCATS NIH HHS KL2 TR002346NCATS NIH HHS TL1 TR002344NCATS NIH HHS UL1 TR002345NIGMS NIH HHS R35 GM126928
6 · The paper itself

Abstract

backgroundFever is common in mechanically ventilated patients and may be uniquely detrimental in those with lung injury because of its injurious effects on pulmonary vascular permeability and alveolar epithelium. We evaluated the association of fever and antipyretic medication with mortality in mechanically ventilated emergency department (ED) patients.

methodsThis is a retrospective cohort study of 1,264 patients requiring mechanical ventilation initiated in the ED with subsequent admission to an intensive care unit. Maximum body temperature was recorded for the first 24 h after ED admission and categorized into four categories: <37°C, 37°C to 38.2°C, 38.3°C to 39.4°C, and ≥39.5°C. The primary outcome was 28-day mortality. We conducted a planned subgroup analysis of patients with sepsis at the time of intubation. Multivariable Cox proportional hazard ratios (HRs) were used to assess the relationship between temperature, antipyretics, and mortality.

resultsMultivariable Cox proportional HRs demonstrated that a maximum temperature ≥39.5°C was associated with increased mortality (adjusted hazard ratio [aHR] 1.59 [95% confidence interval, CI, 1.05-2.39]). In the subgroup of patients with sepsis, a maximum temperature of 38.3°C to 39.4°C was associated with survival (aHR 0.61 [95% CI, 0.39-0.99]). There was no difference in 28-day mortality between patients who did and did not receive antipyretic medication in either the overall cohort or the septic subgroup.

conclusionHigh fever (≥39.5°C) was associated with increased risk for mortality in mechanically ventilated patients. However, in patients with sepsis, moderate fever (38.3°C-39.4°C) was protective. Antipyretic medication was not associated with changes in outcome. This suggests that fever may have different implications in septic versus nonseptic mechanically ventilated patients.

Indexed as

AdultAgedAntipyreticsCohort StudiesCritical IllnessEmergency Service, HospitalFemaleFeverHospital MortalityHumansIntensive Care UnitsMaleMiddle AgedMultivariate AnalysisProportional Hazards ModelsRespiration, ArtificialAntipyretics

Identifiers

PMID31058720
PMCPMC6629479
OpenAlexW2944696250

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.